IUI1 Stock Chart & Stats
€399.60
€9.00(1.73%)
At close: 4:00 PM EST
€399.60
€9.00(1.73%)
Day’s Range― - ―
52-Week Range€341.25 - €516.10
Previous CloseN/A
Volume235.00
Average Volume (3M)307.00
Market Cap
€131.91B
Enterprise Value€140.40B
Total Cash (Recent Filing)€4.55B
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)50.9
Beta0.57
Next Earnings
Jul 16, 2026EPS Estimate
2.2Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)8.37
Shares Outstanding354,162,840
10 Day Avg. Volume217
30 Day Avg. Volume307
Financial Highlights & Ratios
PEG Ratio3.17
Price to Book (P/B)11.34
Price to Sales (P/S)20.08
P/FCF Ratio81.16
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€492.16Price Target Upside23.16% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering19
EPS Forecast (FY)9.13
Revenue Forecast (FY)€10.22B
Bulls Say, Bears Say
Bulls Say
Recurring Revenue / Installed BaseA platform-plus-consumables model with 86% recurring revenue creates durable, high-frequency cash flows tied to procedure volume and installed base growth. This structural revenue mix supports predictability, high operating leverage, and long-term margin sustainability as systems proliferate.
High And Expanding MarginsSustained high gross and operating margins reflect pricing power, product differentiation, and service economics. Margin expansion underpins strong cash generation and reinvestment ability, making profitability resilient to moderate revenue cycles and supporting long-term R&D and commercialization investments.
Strong Cash Flow & Conservative Balance SheetRobust FCF and near-zero leverage provide strategic optionality—funding buybacks, acquisitions, and product rollout without refinancing risk. Consistent cash conversion supports durable capital allocation, weathering cyclical headwinds while enabling targeted investments to sustain growth.
Bears Say
China Market HeadwindsStructural weakness and policy uncertainty in China can materially limit system placements and recurring revenue growth in a major market. Delayed reimbursement clarity and domestic competitive pricing pressure may cap near‑to‑medium term adoption and slow the installed base expansion essential for recurring revenues.
GLP‑1 Impact On Bariatric VolumeWidespread adoption of GLP‑1 therapies represents a secular shift in obesity care that reduces certain surgical volumes. Persistent lower bariatric procedures can structurally depress consumable and service revenue per procedure unless offset by new procedure adoption or product diversification.
Input‑costs And Tariff PressureSustained input‑cost inflation and tariff exposure can compress gross margins if not offset by pricing, productivity, or mix shift. Persistent supply‑chain cost pressures introduce structural margin risk over the medium term and require management action to preserve profitability.
IUI1 FAQ
What was Intuitive Surgical’s price range in the past 12 months?
Intuitive Surgical lowest stock price was €341.25 and its highest was €516.10 in the past 12 months.
What is Intuitive Surgical’s market cap?
Intuitive Surgical’s market cap is €131.91B.
When is Intuitive Surgical’s upcoming earnings report date?
Intuitive Surgical’s upcoming earnings report date is Jul 16, 2026 which is in 13 days.
How were Intuitive Surgical’s earnings last quarter?
Intuitive Surgical released its earnings results on Apr 21, 2026. The company reported €2.186 earnings per share for the quarter, beating the consensus estimate of €1.855 by €0.33.
Is Intuitive Surgical overvalued?
According to Wall Street analysts Intuitive Surgical’s price is currently Undervalued.
Does Intuitive Surgical pay dividends?
Intuitive Surgical does not currently pay dividends.
What is Intuitive Surgical’s EPS estimate?
Intuitive Surgical’s EPS estimate is 2.2.
How many shares outstanding does Intuitive Surgical have?
Intuitive Surgical has 354,162,840 shares outstanding.
What happened to Intuitive Surgical’s price movement after its last earnings report?
Intuitive Surgical reported an EPS of €2.186 in its last earnings report, beating expectations of €1.855. Following the earnings report the stock price went up 6.746%.
Which hedge fund is a major shareholder of Intuitive Surgical?
Currently, no hedge funds are holding shares in DE:IUI1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Intuitive Surgical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€492.16 (23.16% Upside)
€492.16 (23.16% Upside)
Blogger Sentiment
Bullish
DE:IUI1 Sentiment 70%
Sector Average ―
Sector Average ―
News Sentiment
Bullish
Bullish news 75%
Bearish news 25%
Bearish news 25%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-21.19%
12-Months-Change
Fundamentals
Return on Equity
17.01%
Trailing 12-Months
Asset Growth
4.63%
Trailing 12-Months
Company Description
Intuitive Surgical
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.
IUI1 Company Deck
IUI1 Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized strong commercial and financial momentum: double-digit revenue and procedure growth, expanding placements and adoption of new platforms (da Vinci 5, SP, Ion), margin expansion and supportive clinical data. Headwinds were noted but largely manageable in the near term — China and Japan remain challenged, bariatric volume was down due to GLP-1 adoption, there are input-cost and tariff risks, and a contained cybersecurity incident occurred. Overall, positives around growth, profitability, product adoption and clinical validation substantially outweighed the challenges.View all DE:IUI1 earnings summariesIUI1 Revenue Breakdown
67.72% U.S.
32.28% Outside of U.S

IUI1 Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
€492.16
▲(23.16% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Options Prices
Currently, No data available
---










